Hematopoietic cell transplantation for correction of primary immunodeficiencies

Bone Marrow Transplantation

Volumn 42, Issue SUPPL.1, 2008, Pages

  Filipovich, A H ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; FLUDARABINE; IMMUNOSUPPRESSIVE AGENT; THYMOCYTE ANTIBODY;

AGE; BONE MARROW; COMORBIDITY; DONOR; ENTERIC VIRUS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES VIRUS; HLA MATCHING; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; PERIPHERAL BLOOD STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; REDUCED INTENSITY CONDITIONING; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; SIBLING; SURVIVAL RATE; TISSUE TYPING; UMBILICAL CORD BLOOD; VIRUS IMMUNITY; WISKOTT ALDRICH SYNDROME; X CHROMOSOME LINKED DISORDER;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 1; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; SEVERE COMBINED IMMUNODEFICIENCY; WISKOTT-ALDRICH SYNDROME;

EID: 50549086573     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.121     Document Type: Review

References (16)

1. Myers LA, Patel DD, Puck JM, Buckley RH. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 2002; 99: 872-878.
2. Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: Report of the European Experience 1968-99. Lancet 2003; 361: 553-560.
3. Laffort C, Le Deist F, Favre M, Caillat-Zucman S, Radford-Weiss I, Debre M et al. Severe, cutaneous papillomavirus disease after haernopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gamma cytokine receptor subunit or JAK-3 deficiency. Lancet 2004; 363: 2051-2054.
4. Chan K, Puck JM. Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol 2005; 115: 391-398.
5. Grunebaum E, Somech R, Reid B, Roifman Chaim M. Survival and immune function in patients with severe combined immune deficiency after bone marrow transplantation from matched unrelated donors, Proceedings of the XIIth Meeting of ESID, October 2006 page 68.
6. Filipovich AH, Stone J, Tomany SC, Ireland M, Kollman C, Pelz CJ et al. Impact of donor type on outcome of bone marrow transplantation for. Wiskott-Aldrich syndrome: Collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001; 97: 1598-1603.
7. Gennery AR, Khawaja K, Veys P, Bredius RG, Notarangelo LD, Mazzolari E et al. Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: A survey of the European Experience 1993-2002. Blood 2003; 103: 1152-1157.
8. Del Giudice I, Iori AP, Mengarelli A, Testi AM, Romano A, Cerrtti R et al. Allogenic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of literature. Ann Hematol 2003; 82: 189-192.
9. Lankester AC, Visser LF, Hartwig NG, Bredius RG, Gaspar HP, van der Burg M et al. Allogeneic stem cell transplantation ii X-linked lymphoproliferative disease: Two cases in one family and review of the literature. Bone Marrow Transplant 2005; 36: 99-105.
10. Rao A, Kamani N, Filipovich AH, Lee SM, Davies S, Dalal J, Shenoy S. Successful bone marrow transplantation for IPEX syndrome following reduced- intensity conditioning. Blood 2007; 109: 383-385.
11. Horne AC, Janka G, Egeler RM, Gadner H, Imashuku S, Ladisch S et al Hematopoietic stem cell transplantation in hemophagocytic; lmhphohistiocytosis: Results of the HLH-94 Study. Br J Haematol 2005; 129: 622-630.
12. Eapen M, DeLaat C, Baker S, Cairo M, Cowan M, Kurtzberg J et al. Hematopoietic cell transplantation for Chediak-Higashi syndrome. Bone Marrow Transplant 2007; 39: 411-415.
13. Tardieu M, Lacroix C, Neven B, Bordiogoni P, de Saint Basil G, Blanche S et al. Progressive neurologic dysfunctions 20 years after allogenic bone marrow transplantation for Chediak-Higashi syndrome. Blood 2005; 106: 40-42.
14. Neven B, Mahlaoui N, Picard C, Ouachee M, Le Deist F, Cavazzana-Calvo M et al. Long-term follow-up in a large cohort of patients with severe combined immunodeficiency, Proceedings of the XIIth Meeting of ESID, October 2006, page 68.
15. Rao K, Amrolia PJ, Jones A, Cale CM, Naik P, King D et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood 2005; 105: 879-885.
16. Borghans JA, Bredius RG, Hazenberg MD, Roelofs H, Jol-van der Zijde EC, Heidt J et al. Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency. Blood 2006; 108: 763-769.